Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis.
Rana Berru DurmusTumay AkYusuf Ziya ErzinMelike MelikogluEmire SeyahiPublished in: International journal of rheumatic diseases (2023)
Although SEC-related inflammatory adverse events, including vasculitis, are rarely encountered in clinical practice, it is essential to recognize them because they can be mistaken as a component of the underlying inflammatory disease. In addition, the dramatic improvement in many cases after the cessation of SEC underlines the importance of making an accurate diagnosis. Pathogenetically, these adverse events are likely to be paradoxical reactions, except for SEC-induced inflammatory bowel diseases. However, in many aspects, their pathogenesis is controversial and needs clarification.